Book Description

The Global Artificial Pancreas Device System Market size was valued at USD 154.31 million in 2019 and is expected to grow at a CAGR of 20% during the forecast period.

The increasing prevalence of diabetes, intensive research and development efforts by industry players and rising demand for automated systems for glycemic control are the factors driving the market growth. Artificial pancreas device system controls the blood glucose level in diabetes patients, and market players are conducting various researches for improved diabetes management. For instance, Medtronic launched MiniMed 670G, the first hybrid closed loop system, which has the property of self- adjustment to keep sugar level in range. Various other organizations are undertaking initiatives to develop technologically advanced artificial pancreas device system.

Read More @ https://www.reportsanddata.com/report-detail/artificial-pancreas-device-system-apds-market